AstraZeneca | Results Presentation Deck | 44 slides

AstraZeneca · 2022-11
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

44
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
front_matter
Open slide detailBeat · Attention
04
front_matter
Open slide detailBeat · Attention
05
Includes detailed footnotes explaining segment reclassifications and definitions.summarize
Open slide detailBeat · Attention
06
The slide uses a list-based structure to highlight key R&D milestones.summarize
Open slide detailBeat · NeedLoop · Golden Circle
07
Includes definitions for NME, LCM, CVRM, R&I, V&I, US, ERoW in the footer.summarize
Open slide detailBeat · NeedLoop · Golden Circle
08
Includes corporate branding and a molecular visualization.front_matter
Open slide detailBeat · Need
09
Includes footnotes defining CER, operating expenses, and abbreviations.analyze_data
Open slide detailBeat · Satisfaction
10
The slide uses CER (Constant Exchange Rate) for growth comparisons.analyze_data
Open slide detailBeat · Satisfaction
11
Includes Net Debt/EBITDA metrics and credit rating context in footnotes.analyze_data
Open slide detailBeat · Satisfaction
12
The slide uses a timeline-based progression to show guidance upgrades and a bar chart to illustrate the worsening FX headwind.analyze_data
Open slide detailBeat · Satisfaction
13
The slide uses a pie chart to illustrate R&D investment allocation and a list-based framework for commercial investment priorities.present_framework
Open slide detailBeat · Satisfaction
14
summarize
Open slide detailBeat · Satisfaction
15
introduce_nominees
Open slide detailBeat · Satisfaction
16
The chart shows revenue breakdown by product across 7 quarters (Q1 2021 to Q3 2022).analyze_data
Open slide detailBeat · Satisfaction
17
Includes a line chart showing market share trends for Calquence vs competitors in the BTKi class.analyze_data
Open slide detailBeat · Satisfaction
18
Includes Kaplan-Meier survival curves and a waterfall plot for clinical efficacy.analyze_data
Open slide detailBeat · SatisfactionLoop · Aha Moment
19
The slide uses a comparison structure to highlight two distinct drug candidates.summarize
Open slide detailBeat · SatisfactionLoop · Aha Moment
20
Includes a visual representation of drug mechanism in the body.present_solution
Open slide detailBeat · Satisfaction
21
Features headshots of two executives and a molecular visualization.introduce_nominees
22
The slide uses stacked bar charts to show revenue composition by product per quarter for three segments.analyze_data
23
The slide uses a split-screen comparison of two distinct clinical trial datasets.analyze_data
24
Includes footnotes defining abbreviations and trial details.summarize
25
AstraZeneca branding present.front_matter
26
The slide uses a stacked bar chart to show revenue composition over time and a bulleted list to explain Q3 2022 performance drivers.analyze_data
27
The slide uses a three-column layout to categorize strategic initiatives.summarize
28
The slide uses a '+' symbol to represent the acquisition/integration of LogicBio's platforms into Alexion's R&D pipeline.present_solution
29
summarize
30
Includes a detailed legend of medical abbreviations at the bottom.summarize
Open slide detailBeat · Visualization
31
Includes specific Scope 1, 2, and 3 emission reduction targets and a carbon negative goal.summarize
Open slide detailBeat · VisualizationLoop · Cost Of Inaction
32
introduce_nominees
Open slide detailBeat · Visualization
34
The slide uses a custom matrix layout to show drug positioning across patient segments (HER2-high, HR+, HER2-low, etc.) and treatment lines (Early to 3rd-line+)present_framework
35
Includes detailed footnotes regarding pro-forma growth calculations and definitions of EM, CVRM, R&I, and V&I.analyze_data
36
The slide uses a three-column layout to categorize ESG achievements.summarize
37
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
38
The slide compares product revenue (stacked bar) with collaboration revenue (stacked bar) for the drug Lynparza.analyze_data
39
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
40
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
41
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
42
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
43
Data reflects revenue post-acquisition of Alexion on 21 July 2021.analyze_data